Mostrando 726,521 - 726,540 Resultados de 726,717 Para Buscar '"Switzerland"', tiempo de consulta: 3.33s Limitar resultados
  1. 726521
  2. 726522
  3. 726523
  4. 726524
    “…A total of 45 patients treated with second-line single-agent CIT (ie, atezolizumab or otherwise) for advanced or metastatic NSCLC, as well as HCPs, whose exact number was decided by the clinics, were recruited from 10 clinics in Germany, Finland, and Switzerland between February and May 2019. All clinics were provided with the Kaiku Health generic CIT DPMM tool, including our CIT+ module. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  5. 726525
  6. 726526
  7. 726527
    “…METHODS: This international, single-arm, phase 2 trial was done in 24 hospitals in Italy, the UK, the Netherlands, and Switzerland. Adults (aged 18–70 years) with histologically diagnosed diffuse large B-cell lymphoma and CNS involvement at the time of primary diagnosis or at relapse and Eastern Cooperative Oncology Group Performance Status of 3 or less were enrolled and received three courses of MATRix (rituximab 375 mg/m(2), intravenous infusion, day 0; methotrexate 3·5 g/m(2), the first 0·5 g/m(2) in 15 min followed by 3 g/m(2) in a 3 h intravenous infusion, day 1; cytarabine 2 g/m(2) every 12 h, in 1 h intravenous infusions, days 2 and 3; thiotepa 30 mg/m(2), 30 min intravenous infusion, day 4) followed by three courses of RICE (rituximab 375 mg/m(2), day 1; etoposide 100 mg/m(2) per day in 500–1000 mL over a 60 min intravenous infusion, days 1, 2, and 3; ifosfamide 5 g/m(2) in 1000 mL in a 24 h intravenous infusion with mesna support, day 2; carboplatin area under the curve of 5 in 500 mL in a 1 h intravenous infusion, day 2) and carmustine–thiotepa and autologous HSCT (carmustine 400 mg/m(2) in 500 mL glucose 5% solution in a 1–2 h infusion, day −6; thiotepa 5 mg/kg in saline solution in a 2 h infusion every 12 h, days −5 and −4). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  8. 726528
  9. 726529
  10. 726530
  11. 726531
  12. 726532
  13. 726533
  14. 726534
  15. 726535
  16. 726536
  17. 726537
    “…METHODS: A total of 21 university centers for radiation oncology from five different European countries (Germany, Switzerland, Spain, Belgium, and Austria) participated in the study which evaluated n = 347 patients with confirmed (biopsy) inoperable NSCLC in UICC stage III A/B who received radical curative-intent RCT between 2010 and 2013. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  18. 726538
  19. 726539
  20. 726540
Herramientas de búsqueda: RSS